[Current Data] Rule running report - 2024-11-25 08:47:49.474214

Nr2MedPage Today) -- For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX bioadaptor not only matched drug-eluting stents (DES) in early performance but seemed to keep stent-related events… succesfully run! 0 Anläufe!